Christopher Marshall

Dr. Christopher P. Marshall, a seasoned entrepreneur and biotech expert, has a stellar track record of founding and co-founding successful biotech start-up companies addressing critical healthcare needs. He is the President and Chief Executive Officer at Calder Biosciences Inc., a company focused on developing a vaccine enabling technology that enhances the performance of vaccine immunogens.

With a strong passion for addressing cognitive impairment, anxiety, depression, and pain, Dr. Marshall also co-founded Ophidion, Inc., where he served as the Chief Executive Officer. Ophidion Inc. leverages technology licensed from Rockefeller University/HHMI to increase target specificity, drug efficacy, and lower the risk of addiction in the treatment of these conditions.

In addition to his roles at Calder Biosciences and Ophidion, Dr. Marshall is the Founder and Managing Partner at Marshall IP Services, LLC, demonstrating his expertise in intellectual property and patent matters. Furthermore, he has experience as the Founder and Chief Executive Officer at Avatar Biotechnologies, LLC, a company specializing in improving biocatalytic enzymes and protein chips.

Dr. Marshall's extensive career also includes a stint as a management consultant at Oliver Wyman & Co., where he worked on risk management and general strategy projects with European banks, showcasing his versatility in the biotech and business domains. With a Ph.D. in Biomedical Research from The Rockefeller University, Dr. Marshall brings a wealth of scientific knowledge and entrepreneurial acumen to the biotech industry.